Dual RPDD and ODD for FL118 in osteosarcoma create regulatory incentives that may accelerate development for a rare, aggressive pediatric/AYA bone cancer with limited recurrent-disease options. FL118 ...
Roswell Park urology experts shared studies at AUA 2026 on bladder and prostate cancer risk, pelvic floor neural mapping and ...
In the U.S., 168 healthcare organizations have received accreditation for immune effector cell therapy from the Foundation for the Accreditation of Cellular Therapy. An additional seven received ...
Versiti's $79 million, 80,000-square-foot expansion of its blood research institute is planned to open in December. Logan Hanson | MBJ To continue reading this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results